Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)

Published:2019-01 Issue:1 Volume:20 Page:43-47
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Elamin Yasir Y.,Gomez Daniel R.,Antonoff Mara B.,Robichaux Jacqulyne P.,Tran Hai,Shorter Melissa K.,Bohac Jadi M.,Negrao Marcelo Vailati,Le Xiuning,Rinsurogkawong Waree,Lewis Jeff,Lacerda Lara,Roarty Emily B.,Swisher Stephen G.,Roth Jack A.,Zhang Jianjun,Papadimitrakopoulou Vassiliki,Heymach John V.

Funder

University of Texas

MD Anderson Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Comprehensive molecular analysis of NSCLC; clinicopathological associations;Chatziandreou;PLoS One,2015

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

5. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials;Yang;Lancet Oncol,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer;JAMA Oncology;2024-07-01

2. Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient Care;International Journal of Radiation Oncology*Biology*Physics;2024-04

3. Additional local therapy before disease progression for EGFR-mutated advanced lung cancer: a systematic review and meta-analysis;Translational Lung Cancer Research;2024-03

5. Lung cancer in patients who have never smoked — an emerging disease;Nature Reviews Clinical Oncology;2024-01-09